Research progress on the role of PDGF/PDGFR in type 2 diabetes.

Zhanqi Cao, Yijie Liu, Yini Wang, Ping Leng

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2023;164():114983

PMID: 37290188

Abstract

Platelet-derived growth factors (PDGFs) are basic proteins stored in the α granules of platelets. PDGFs and their receptors (PDGFRs) are widely expressed in platelets, fibroblasts, vascular endothelial cells, platelets, pericytes, smooth muscle cells and tumor cells. The activation of PDGFR plays a number of critical roles in physiological functions and diseases, including normal embryonic development, cellular differentiation, and responses to tissue damage. In recent years, emerging experimental evidence has shown that activation of the PDGF/PDGFR pathway is involved in the development of diabetes and its complications, such as atherosclerosis, diabetic foot ulcers, diabetic nephropathy, and retinopathy. Research on targeting PDGF/PDGFR as a treatment has also made great progress. In this mini-review, we summarized the role of PDGF in diabetes, as well as the research progress on targeted diabetes therapy, which provides a new strategy for the treatment of type 2 diabetes.

Copyright © 2023 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Address: Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao 266003, China.; Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao 266003, China. Electronic address: [email protected].
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.